INTRODUCTION. There has been some recent concern regarding possible systemic health effects resulting from elevated blood cobalt concentrations in patients with cobalt containing hip implants. To date there are no blood cobalt criteria to help guide physicians when evaluating an
Chelation in suspected prosthetic hip-associated cobalt toxicity.
Andrea Giampreti et al.
The Canadian journal of cardiology, 30(4), 465-465 (2014-02-13)
Biochimica et biophysica acta, 1838(5), 1247-1254 (2014-02-11)
Three amphiphilic cobalt-cage congeners bearing a diaza-crown bridge and varying alkyl chains (1:2:3; n = 12, 16, 18) have been assessed for their ion transport across planar lipid bilayer membranes. In symmetrical electrolyte solutions, a range of ion transport activity
Journal of nanoscience and nanotechnology, 14(6), 4286-4291 (2014-04-18)
Cobalt Oxide (Co3o4) thin films have been successfully coated onto glass substrates at various solution pH by sol-gel spin coating technique. The film thickness was estimated using weight gain method and it revealed that the film thickness increased with solution
Journal of medical toxicology : official journal of the American College of Medical Toxicology, 9(4), 405-415 (2013-11-14)
Safety concerns regarding cobalt-containing metal alloy hip prosthetics (Co-HP) have resulted in product recalls, a medical device alert, and issuance of guidance for clinicians. Recently, cases of suspected prosthetic hip-associated cobalt toxicity (PHACT) from Co-HP have been reported. Although little
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
